Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P400PM_183865)
Gottfried und Julia Bangerter-Rhyner-Stiftung (NA)
Received: 23 May 2020
Accepted: 12 July 2020
First Online: 23 July 2020
Ethics approval and consent to participate
: Both studies were approved by the national ethics committee.
: Not applicable.
: The authors declare that they have no competing interests. JFT received fees for lectures to 3 M, MSD, Pfizer, and Biomerieux. JFT received research grants from Astellas, 3 M, MSD, and Pfizer. JFT participated to advisory boards of 3 M, MSD, Bayer Pharma, Nabriva, and Pfizer. JCL received fees for lectures for 3 M, Pfizer MSD, and research grants from Anios. OM received fees for lectures for 3 M and BD. OM received research grants from BD.